Ensysce Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ensysce Biosciences, Inc. on June 5, 2025, regarding events occurring on June 3, 2025. The Company is a Delaware corporation with principal executive offices in La Jolla, California, and its common stock trades on The Nasdaq Stock Market LLC under the symbol "ENSC".
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the current period. However, it references the independent audit report for the years ended December 31, 2024, and 2023, which contained an explanatory paragraph regarding a going concern uncertainty.
Material Changes
The primary material change disclosed is the resignation of Moss Adams LLP as the Company's independent registered public accounting firm and the appointment of Baker Tilly US, LLP as its successor. This change resulted from the merger of Moss Adams LLP with Baker Tilly US, LLP, effective June 3, 2025. The Audit Committee approved the appointment of Baker Tilly as the successor firm effective as of the merger date.
Outlook, Risks, and Contingencies
- Going Concern: The prior audit report for the periods ended December 31, 2024, and 2023 included an explanatory paragraph regarding a going concern uncertainty.
- Audit Disagreements: The Company reported no disagreements with Moss Adams LLP regarding accounting principles, practices, financial statement disclosures, or auditing scope/procedures during the years ended December 31, 2024 and 2023, or the interim period through June 3, 2025.
- Consultations: No consultations were held with Baker Tilly regarding accounting principles or potential audit opinions prior to the appointment.
Investor Verification Checklist
- Verify the status of the "going concern" uncertainty noted in the December 31, 2024, audit report.
- Review the letter from Moss Adams LLP (Exhibit 16.1) to confirm their agreement with the statements regarding the change in auditors.
- Monitor future filings for updated financial statements prepared under the new auditor, Baker Tilly US, LLP.
- Confirm that no undisclosed reportable events or disagreements existed during the transition period.